Composition for transdermal penetration of medicaments
    4.
    发明授权
    Composition for transdermal penetration of medicaments 失效
    用于药物透皮渗透的组合物

    公开(公告)号:US5149719A

    公开(公告)日:1992-09-22

    申请号:US515198

    申请日:1990-04-27

    IPC分类号: A61K9/00 A61K47/10

    摘要: A composition, and method of preparing such a composition, useful for the enhancement of the transdermal delivery of a medicament. The composition includes a medicament suspended in an aqueous solution of lower alcohol, to which solution is added an amount of higher alcohol sufficient to substantially saturate the composition.

    摘要翻译: 制备这种组合物的组合物和方法,其可用于增强药物的透皮递送。 该组合物包括悬浮在低级醇水溶液中的药物,向该溶液中加入足以使组合物基本上饱和的量的高级醇。

    Diagnostic radio-labeled polysaccharide derivatives
    5.
    发明授权
    Diagnostic radio-labeled polysaccharide derivatives 失效
    诊断放射性标记多糖衍生物

    公开(公告)号:US4385046A

    公开(公告)日:1983-05-24

    申请号:US216685

    申请日:1980-12-15

    摘要: A novel class of chelated radio-labeled polysaccharide derivatives are useful for diagnosing formed, and forming, blood clots in a vascular system. Novel intermediate metal-binding compounds comprise a water-soluble polysaccharide moiety having an average of at least 0.25 anionic groups per monosaccharide unit, and at least one chelating group derived from amino acids, substituted cyclic acid anhydrides, or carbon disulfide. The intermediate compound is then reacted with a radioactive tracer metal compound.

    摘要翻译: 一类新型的螯合放射性标记多糖衍生物可用于诊断血管系统中形成和形成血块。 新的中间体金属结合化合物包含每个单糖单元平均具有至少0.25个阴离子基团的水溶性多糖部分和至少一种衍生自氨基酸的螯合基团,取代的环状酸酐或二硫化碳。 然后使中间体化合物与放射性示踪剂金属化合物反应。